Shares of Orion Oyj (OTCMKTS:ORINY - Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $17.50 and last traded at $17.50, with a volume of 78 shares traded. The stock had previously closed at $17.50.
Orion Oyj Price Performance
The company has a market cap of $4.94 billion, a P/E ratio of 20.83 and a beta of 0.23. The company has a debt-to-equity ratio of 0.21, a current ratio of 3.10 and a quick ratio of 1.59. The company has a 50 day moving average of $18.54 and a 200-day moving average of $20.14.
Orion Oyj (OTCMKTS:ORINY - Get Free Report) last posted its quarterly earnings data on Tuesday, February 13th. The company reported $0.29 earnings per share for the quarter. The company had revenue of $345.76 million for the quarter. Orion Oyj had a net margin of 17.74% and a return on equity of 26.81%. On average, equities analysts predict that Orion Oyj will post 0.89 earnings per share for the current year.
Orion Oyj Company Profile
(
Get Free Report)
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Orion Oyj, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Orion Oyj wasn't on the list.
While Orion Oyj currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
